Big Pharmas Cite Elevator Ruling To Boost Case
Sixteen prominent pharmaceutical manufacturers have pointed to a recent appellate decision as further proof that they should be dismissed from a Long Island-based drug wholesaler's $2.3 billion antitrust suit....To view the full article, register now.
Already a subscriber? Click here to view full article